TAKEDA PHARMACEUTICAL CO LTD (TAK) - Dilution Analysis

Visualizing historical and potential share dilution over time

View Stock Details

American Express® Business Gold Card

Earn Up to 200K Membership Rewards® Points

4X on your top 2 spending categories. Transfer to 20+ airline & hotel partners. Terms apply.

Learn More

Dilution Analysis

Low Risk

Limited dilution potential

Last updated: June 25, 2025

Risk Assessment Details

Potential Dilution: 0.0% of current shares

Recent Dilution: 2.76% (2 years)

Historical Dilution Factor: minimal recent dilution

Outstanding Shares

120M

Potential Supply

Additional shares possible

Splits

None

Past 2 years

Summary

TAK currently has 123M outstanding shares. with minimal authorized share overhang for future dilution. The company has minimally diluted shareholders by 2.76% over the past 2 years.

Share Structure Timeline

Outstanding Shares

Total Supply

Historical Data Points

Date	Event	Outstanding
Jun 25, 2025	20-F filing \| 123.5M shares outstanding	120M
Jun 26, 2024	20-F filing \| 120.2M shares outstanding	120M
Jun 28, 2023	20-F filing \| 139.7M shares outstanding	140M
Jun 29, 2022	20-F filing \| 115.7M shares outstanding	120M
Jun 29, 2021	20-F filing \| 157.1M shares outstanding	160M
Jun 24, 2020	20-F filing \| 1557.8M shares outstanding	1.6B
Feb 26, 2020	POS AM filing: This post-effective amendment deregisters unsold securities from a previous exchange offer, including $1,000,000,000 of 2020 Exchange Notes, $12,450,000 of 2021 Exchange Notes, $4,436,000 of 2023 Exchange Notes, and $22,185,000 of 2028 Exchange Notes.	N/A

Back to TAK Details